Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study.
Slob EMA, Brew BK, Vijverberg SJH, Kats CJAR, Longo C, Pijnenburg MW, van Beijsterveldt TCEM, Dolan CV, Bartels M, Magnusson P, Lichtenstein P, Gong T, Koppelman GH, Almqvist C, Boomsma DI, Maitland-van der Zee AH. Slob EMA, et al. Eur Respir J. 2020 Apr 23;55(4):1902021. doi: 10.1183/13993003.02021-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 32139457 Free article.
Treatment response heterogeneity in asthma: the role of genetic variation.
Vijverberg SJH, Farzan N, Slob EMA, Neerincx AH, Maitland-van der Zee AH. Vijverberg SJH, et al. Among authors: slob ema. Expert Rev Respir Med. 2018 Jan;12(1):55-65. doi: 10.1080/17476348.2018.1403318. Epub 2017 Nov 21. Expert Rev Respir Med. 2018. PMID: 29115880 Review.
What do we need to transfer pharmacogenetics findings into the clinic?
Slob EMA, Vijverberg SJH, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH. Slob EMA, et al. Pharmacogenomics. 2018 May;19(7):589-592. doi: 10.2217/pgs-2018-0026. Epub 2018 Apr 27. Pharmacogenomics. 2018. PMID: 29701121 Free article. No abstract available.
Early-life antibiotic use and risk of attention-deficit hyperactivity disorder and autism spectrum disorder: results of a discordant twin study.
Slob EMA, Brew BK, Vijverberg SJH, Dijs T, van Beijsterveldt CEM, Koppelman GH, Bartels M, Dolan CV, Larsson H, Lundström S, Lichtenstein P, Gong T, Maitland-van der Zee AH, Kraneveld AD, Almqvist C, Boomsma DI. Slob EMA, et al. Int J Epidemiol. 2021 May 17;50(2):475-484. doi: 10.1093/ije/dyaa168. Int J Epidemiol. 2021. PMID: 33179025 Free PMC article.
Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.
Slob EMA, Richards LB, Vijverberg SJH, Longo C, Koppelman GH, Pijnenburg MWH, Bel EHD, Neerincx AH, Herrera Luis E, Perez-Garcia J, Tim Chew F, Yie Sio Y, Andiappan AK, Turner SW, Mukhopadhyay S, Palmer CNA, Hawcutt D, Jorgensen AL, Burchard EG, Hernandez-Pacheco N, Pino-Yanes M, Maitland-van der Zee AH. Slob EMA, et al. Pediatr Allergy Immunol. 2021 Aug;32(6):1197-1207. doi: 10.1111/pai.13494. Epub 2021 Mar 29. Pediatr Allergy Immunol. 2021. PMID: 33706416 Free PMC article.
Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response.
Slob EMA, Faiz A, van Nijnatten J, Vijverberg SJH, Longo C, Kutlu M, Chew FT, Sio YY, Herrera-Luis E, Espuela-Ortiz A, Perez-Garcia J, Pino-Yanes M, Burchard EG, Potočnik U, Gorenjak M, Palmer C, Maroteau C, Turner S, Verhamme K, Karimi L, Mukhopadhyay S, Timens W, Hiemstra PS, Pijnenburg MW, Neighbors M, Grimbaldeston MA, Tew GW, Brandsma CA, Berce V, Aliee H, Theis F, Sin DD, Li X, van den Berge M, Maitland-van der Zee AH, Koppelman GH. Slob EMA, et al. Clin Transl Allergy. 2022 Aug;12(8):e12173. doi: 10.1002/clt2.12173. Clin Transl Allergy. 2022. PMID: 36036237 Free PMC article. No abstract available.
Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study.
Alizadeh Bahmani AH, Slob EMA, Bloemsma LD, Brandstetter S, Corcuera-Elosegui P, Gorenjak M, Harner S, Hashimoto S, Hedman AM, Kabesch M, Koppelman GH, Korta-Murua J, Kraneveld AD, Neerincx AH, Pijnenburg MW, Pino-Yanes M, Potočnik U, Sardón-Prado O, Vijverberg SJH, Wolff C, Abdel-Aziz MI, Maitland-van der Zee AH; SysPharmPediA consortium. Alizadeh Bahmani AH, et al. Among authors: slob ema. Eur J Pharm Sci. 2023 Feb 1;181:106360. doi: 10.1016/j.ejps.2022.106360. Epub 2022 Dec 13. Eur J Pharm Sci. 2023. PMID: 36526249 Free article.
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Aman J, Duijvelaar E, Botros L, Kianzad A, Schippers JR, Smeele PJ, Azhang S, Bartelink IH, Bayoumy AA, Bet PM, Boersma W, Bonta PI, Boomars KAT, Bos LDJ, van Bragt JJMH, Braunstahl GJ, Celant LR, Eger KAB, Geelhoed JJM, van Glabbeek YLE, Grotjohan HP, Hagens LA, Happe CM, Hazes BD, Heunks LMA, van den Heuvel M, Hoefsloot W, Hoek RJA, Hoekstra R, Hofstee HMA, Juffermans NP, Kemper EM, Kos R, Kunst PWA, Lammers A, van der Lee I, van der Lee EL, Maitland-van der Zee AH, Mau Asam PFM, Mieras A, Muller M, Neefjes ECW, Nossent EJ, Oswald LMA, Overbeek MJ, Pamplona CC, Paternotte N, Pronk N, de Raaf MA, van Raaij BFM, Reijrink M, Schultz MJ, Serpa Neto A, Slob EMA, Smeenk FWJM, Smit MR, Smits AJ, Stalenhoef JE, Tuinman PR, Vanhove ALEM, Wessels JN, van Wezenbeek JCC, Vonk Noordegraaf A, de Man FS, Bogaard HJ. Aman J, et al. Among authors: slob ema. Lancet Respir Med. 2021 Sep;9(9):957-968. doi: 10.1016/S2213-2600(21)00237-X. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147142 Free PMC article. Clinical Trial.
16 results